Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

PMS-FLUCONAZOLE 50 MG

FLUCONAZOLE : 50 MG · DIN 02245643 · PHARMASCIENCE INC

Health Canada status: MARKETED

What is PMS-FLUCONAZOLE?

PMS-FLUCONAZOLE 50 MG contains FLUCONAZOLE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02245643, held by PHARMASCIENCE INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 05-Jun-2002. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is PMS-FLUCONAZOLE used for?

pms-FLUCONAZOLE (fluconazole) is indicated for the treatment of oropharyngeal and esophageal candidiasis, serious systemic candidal infections (including urinary tract infection, peritonitis, and pneumonia), and cryptococcal meningitis. It is also indicated for the prevention of the recurrence of cryptococcal meningitis in patients with AIDS and to decrease the incidence of candidiasis in patients undergoing bone marrow transplantation who receive cytotoxic chemotherapy and/or radiation therapy.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

What else is PMS-FLUCONAZOLE called?

The same molecule, FLUCONAZOLE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
CANAFLUCANLatinMorocco
DiflucanLatinAustralia, Bahrain, Morocco
NOMYCLatinMorocco
MYNAZOLLatinMorocco
FLUCAZOLLatinBahrain, Morocco
Aspen FluconazoleLatinSouth Africa
FONGICANLatinMorocco
MYCOFLULatinMorocco
TRINOMYCLatinMorocco
CANDICIDLatinMorocco
Fluconazole SandozLatinAustralia
FLUGIZOLLatinMorocco
FLUMYKLatinMorocco
IMIDAZOLLatinMorocco
OzoleLatinAustralia

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

Product details and regulatory record

DIN02245643
Brand namePMS-FLUCONAZOLE
Generic / active ingredientFLUCONAZOLE : 50 MG
ManufacturerPHARMASCIENCE INC
Strength50 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeJ02AC01 FLUCONAZOLE
AHFS class08:14.08
BiosimilarNo
Health Canada statusMARKETED
Status date05-Jun-2002
Original market date2002-06-05 00:00:00

How is this product identified?

Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.

DIN (8-digit, as used in Nexara ordering)02245643
DIN (unpadded, as printed on some documents)2245643
Brand namePMS-FLUCONAZOLE
Active ingredient / INNFLUCONAZOLE : 50 MG
ATC codeJ02AC01
ATC anatomical main groupJ — Anti-infectives for systemic use
ATC therapeutic subgroupJ02
AHFS class08:14.08
Health Canada schedulePrescription
Biosimilar biologicNo
Market authorization holderPHARMASCIENCE INC

Health Canada approved product monograph (PDF)

How is it stored and handled?

null

How is it supplied?

Bottles of 50 and 100 tablets

Which pack is which?

Strength on the label50 MG
Dosage formTABLET
RouteORAL
Packaging as described in the monographBottles of 50 and 100 tablets
Storagenull

One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Confirm the pack and get a price

What can be used instead?

Other Canadian products sharing ATC code J02AC01 FLUCONAZOLE. 29 of 71 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
ACT FLUCONAZOLE100 MGTABLETTEVA CANADA LIMITEDMARKETEDDIN 02281279
ACT FLUCONAZOLE50 MGTABLETTEVA CANADA LIMITEDMARKETEDDIN 02281260
AG-FLUCONAZOLE150 MGCAPSULEANGITA PHARMA INC.MARKETEDDIN 02555891
APO-FLUCONAZOLE100 MGTABLETAPOTEX INCMARKETEDDIN 02237371
APO-FLUCONAZOLE50 MGTABLETAPOTEX INCMARKETEDDIN 02237370
APO-FLUCONAZOLE-150150 MGCAPSULEAPOTEX INCMARKETEDDIN 02241895
BIO-FLUCONAZOLE150 MGCAPSULEBIOMED PHARMAMARKETEDDIN 02462168
CANESORAL150 MGCAPSULEBAYER INCMARKETEDDIN 02311690
DIFLUCAN2 MGSOLUTIONPFIZER CANADA ULCMARKETEDDIN 00891835
DIFLUCAN50 MG / 5 MLPOWDER FOR SOLUTIONPFIZER CANADA ULCMARKETEDDIN 02024152

Who else supplies FLUCONAZOLE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. FLUCONAZOLE appears in 503 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How much does FLUCONAZOLE cost around the world?

FLUCONAZOLE is listed on 9 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Bahrain publishes a retail (max); Greece publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
MoroccoPPV (public price)2993MAD███.██
Greeceproducer price (ex-factory)6767EUR███.██
United Statesacquisition664USD███.██
South Africasingle exit price5062ZAR███.██
Saudi Arabiapublic3337SAR███.██
United Arab Emiratespublic1618AED███.██
Australiaex-manufacturer916AUD███.██
Bahrainretail (max)1216BHD███.██
United Kingdomhospital88GBP███.██

381 pack listings across 230 brand entries and 8 price bases, refreshed 08 Sep 2026. Ranges span every FLUCONAZOLE pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.

Ask Nexara for a landed Canadian price

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for PMS-FLUCONAZOLE

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02245643. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.